> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Abbott Plans To Spin Off $8.5 Billion Nutrition Business By End Of 2027
- URL: https://www.bullished.co/abbott-plans-to-spin-off-8-5-billion-nutrition-business-by-end-of-2027-5afeb40c/
- Published: 2026-10-21T13:26:03.000Z
- Updated: 2026-10-28T19:08:54.000Z
- Description: The maker of Similac and Ensure would become a separate public company, with Abbott keeping about $42 billion in sales.
- Author: Matteo Parrino
- Tags: SEC Filings, ABT, Industry: Healthcare

[Abbott](https://www.bullished.co/tag/abt/) intends to separate its Nutrition business, which has approximately [$8.5 billion in annual sales](https://www.sec.gov/Archives/edgar/data/0000001800/000110465926117587/tm2627971d1%5Fex99-1.htm?ref=bullished.co), into an independent public company, according to an [8-K filed Wednesday](https://www.sec.gov/Archives/edgar/data/0000001800/000110465926117587/tm2627971d1%5F8k.htm?ref=bullished.co). Abbott shareholders would receive shares of the new company through a distribution the company [intends to be tax-free](https://www.prnewswire.com/news-releases/abbott-announces-its-intention-to-separate-its-global-nutrition-business-into-an-independent-publicly-traded-company-302915339.html?ref=bullished.co) for U.S. federal income tax purposes.

## What the filing says

The [8-K](https://www.bullished.co/learn/8-k-items-explained/) attaches a press release dated Wednesday. Abbott expects to finish the separation by the end of 2027\. That is subject to regulatory approvals, an effective registration statement on Form 10 and final approval from its board.

The new company would have [about 16,000 employees](https://www.prnewswire.com/news-releases/abbott-announces-its-intention-to-separate-its-global-nutrition-business-into-an-independent-publicly-traded-company-302915339.html?ref=bullished.co) and 14 manufacturing sites. Its brands include Similac, PediaSure, Pedialyte, Glucerna and Ensure. Daniel Salvadori, now executive vice president and group president, Established Pharmaceuticals and Nutritional Products, will become its chief executive.

After the split, Abbott would have sales of approximately $42 billion and about 106,000 employees. It would keep cardiovascular and neuromodulation devices, biowearables, diagnostics and established medicines.

Chairman and CEO Robert B. Ford said the separation "will benefit both companies."

## What it changes for holders

Shareholders would end up owning shares in both companies. Abbott expects the combined dividend from the two to equal Abbott's dividend at the time of separation.

The separation will not affect Abbott's 2026 guidance, or the 2027 guidance it plans to give in January. Abbott expects one-time charges before the split, to be quantified later. The Nutrition business stays inside Abbott until then.

Abbott shares closed at $102.45 on Tuesday, down 1.55% on the session, before the announcement. Abbott said it would discuss the plan on its third-quarter earnings call Wednesday at 9 a.m. Eastern.

Abbott's January 2027 guidance is the next dated event, and the one-time separation charges have yet to be quantified.

Learn

- [Item 8.01: other events →](https://www.bullished.co/learn/8-k-items-explained/#item-801-other-events)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — ABBOTT LABORATORIES (ABT)](https://www.sec.gov/Archives/edgar/data/0000001800/000110465926117587/tm2627971d1%5F8k.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit tm2627971d1\_ex99-1.htm — ABBOTT LABORATORIES 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0000001800/000110465926117587/tm2627971d1%5Fex99-1.htm?ref=bullished.co) — SEC EDGAR
- [Abbott Stock Falls After Earnings. It’s Shedding Its Troubled Nutrition Unit.](https://www.barrons.com/articles/abbott-labs-earnings-stock-price-spinoff-4179c9e7?mod=hp%5Flatestnews&ref=bullished.co) — Barron's
- [Abbott plans to spin off nutrition business, cuts 2026 sales growth view | Sacramento Bee](https://www.sacbee.com/entertainment/living/article317713289.html?ref=bullished.co) — Reuters
- [Abbott stock slips on plans to separate nutrition unit (ABT) | Seeking Alpha](https://seekingalpha.com/news/4655104-abbott-stock-slips-plans-separate-nutrition-unit?ref=bullished.co) — seekingalpha.com
- [Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company](https://www.prnewswire.com/news-releases/abbott-announces-its-intention-to-separate-its-global-nutrition-business-into-an-independent-publicly-traded-company-302915339.html?ref=bullished.co) — prnewswire.com

### More on Abbott Laboratories

- [Abbott CEO Says Barron's 'Got It Totally Wrong' On Nutrition Spinoff, Calls It A Move From Strength](https://www.bullished.co/abbott-ceo-says-barrons-got-it-totally-wrong-on-nutrition-spinoff-calls-it-a-move-from-d9ea317d/)
- [Abbott's Third-Quarter Sales Rose 14.5%, But Reported Earnings Per Share Fell To $0.53 From $0.94](https://www.bullished.co/abbotts-third-quarter-sales-rose-14-5-but-reported-earnings-per-share-fell-to-0-53-from-0-1f51fad6/)

[All Abbott Laboratories (ABT) coverage →](https://www.bullished.co/tag/abt/)